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Abstract
Background: In higher income countries, social disadvantage is associated with higher arthritis prevalence; however,
less is known about arthritis prevalence or determinants in low to middle income countries (LMICs). We assessed
arthritis prevalence by age and sex, and marital status and occupation, as two key parameters of socioeconomic
position (SEP), using data from the World Health Organization Study on global AGEing and adult health (SAGE).
Methods: SAGE Wave 1 (2007–10) includes nationally-representative samples of older adults (≥50 yrs), plus smaller
samples of adults aged 18-49 yrs., from China, Ghana, India, Mexico, Russia and South Africa (n = 44,747). Arthritis was
defined by self-reported healthcare professional diagnosis, and a symptom-based algorithm. Marital status and
education were self-reported. Arthritis prevalence data were extracted for each country by 10-year age strata, sex and
SEP. Country-specific survey weightings were applied and weighted prevalences calculated.
Results: Self-reported (lifetime) diagnosed arthritis was reported by 5003 women and 2664 men (19.9% and 14.1%,
respectively), whilst 1220 women and 594 men had current symptom-based arthritis (4.8% and 3.1%, respectively). For
men, standardised arthritis rates were approximately two- to three-fold greater than for women. The highest rates were
observed in Russia: 38% (95% CI 36%–39%) for men, and 17% (95% CI 14%–20%) for women. For both sexes and in all
LMICs, arthritis was more prevalent among those with least education, and in separated/divorced/widowed women.
Conclusions: High arthritis prevalence in LMICs is concerning and may worsen poverty by impacting the ability to
work and fulfil community roles. These findings have implications for national efforts to prioritise arthritis prevention
and management, and improve healthcare access in LMICs.
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Background
Worldwide, musculoskeletal disorders represent a global
threat to healthy ageing [1], and are ranked as the sec-
ond most common cause of disability, measured by years
lived with disability (YLDs) [2]. Lower and middle in-
come countries (LMICs) are not immune to the burden
of musculoskeletal diseases, indeed the prevalence of this
non-communicable disease (NCD) group is dramatically
increasing in LMICs [3]. The 2010 Global Burden of
Disease (GBD) study reported that musculoskeletal dis-
eases accounted for 19.2% of all YLDs in LMICs [3].
Despite this, the majority of the global NCD initiatives
do not include musculoskeletal diseases [3]. Significantly
contributing to the global disability burden associated
with the musculoskeletal system are arthritis diseases.
Arthritis is an umbrella term that encompasses in ex-
cess of 100 different arthritic conditions which are a
chronic, painful, and debilitating group of diseases.
Arthritis, specifically osteoarthritis, is a significant
contributor to global disability burden, and the YLDs
attributable to osteoarthritis have increased by 75%
from 1990 to 2013 [2], indicating this disease as a
growing problem internationally. In combination with
an increasing trajectory of arthritis prevalence [2, 4],
growth in YLDs attributable to arthritis is due pri-
marily to increased life expectancy worldwide, and
prolonged exposure to arthritis risk factors [5].
Compared to higher income countries, many LMICs
[6], where two-thirds of the world’s population resides,
have a much lower capacity to pay for adequate health-
care. Indeed, LMICs have 90% of the global burden of
disease but only 12% of global health spending [7]. In
higher income countries, arthritis is associated with re-
duced workplace productivity [8, 9]; however, for resi-
dents of LMICs, arthritis imposes a potential additional
burden by creating a vicious cycle that subsequently
worsens poverty [10]. For example, compared to higher
income countries, and in context of scarce medical
and social support systems, residents of LMICs with
arthritis also experience reduced ability to access,
afford or utilize treatments including analgesic and
anti-inflammatory pharmacotherapies [11, 12], or
arthroplasty for advanced disease [13, 14]. They also
have, in context of workforce capacity limitations, less
flexibility regarding working conditions or hours [15],
and few if any options for early retirement, or social
security ‘safety nets’ pertaining to minimum income,
including financial and/or material goods.
Whilst the majority of research regarding arthritis
prevalence has been undertaken in higher income coun-
tries, recent data from the 2010 GBD Study provides
some evidence that LMICs may have greater arthritis
prevalence than higher income countries [16]. Yet, while
valuable population level estimates, extrapolation from
these GBD estimates is difficult given that they are based
on published prevalence and incidence data from a small
number of heterogeneous studies spanning different
time periods in a limited number of LMIC [17]. Further-
more, data from multi-country studies of LMICs that
have examined prevalence of arthritis across sociodemo-
graphic factors are typically not readily available [18, 19],
with the exception of a recent publication, which
showed that more years of schooling and greater levels
of wealth decreased the odds of having an undiagnosed
NCD, including arthritis [20]. Understanding the preva-
lence of arthritis across different parameters of socioeco-
nomic position (SEP) data would augment our global
understanding of global arthritis prevalence, social deter-
minants and burden.
To date, country-specific arthritis prevalence across
parameters of SEP has not been systematically evalu-
ated in large, nationally representative samples of
populations from LMICs. This information is crucial
for planning future healthcare delivery for high bur-
den chronic conditions and to ensure sufficient
health workforce capacity – both significant concerns
in an ageing world [21]. Comprehensive data have
been collected in the World Health Organization
(WHO) Study on global AGEing and adult health
(SAGE) [20, 22, 23], thus providing an important re-
source to investigate disease prevalence in large
population samples from six LMICs. Using SAGE
Wave 1, these analyses were undertaken to determine
the prevalence of arthritis in LMICs according to
age, sex, and socioeconomic position (SEP).
Methods
Study population and design
SAGE Wave 1 (2007–10) is a longitudinal study with na-
tionally representative samples of persons aged 50+ years
and a smaller sample of adults aged 18–49 years that in-
cludes 44,747 adults aged ≥18 years from China, Ghana,
India, Mexico, Russian Federation and South Africa [23].
Multistage cluster sampling strategies were used with
households as sampling units. Households were classi-
fied into one of two mutually exclusive categories: i) all
persons aged 50 years and older were selected from
“older” households, and ii) one person aged 18–49 years
was selected from each “younger” household. An older
or younger household was defined by the age of the re-
spondent targeted for individual interview. Household-
level and person-level analysis weights were calculated
for each country. This research was performed in ac-
cordance with the Declaration of Helsinki. The WHO
and the respective implementing agency in each country
provided ethics approvals. Written, informed consent
was obtained from all participants.
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Data collection in WHO SAGE
Using a standardized survey instrument to ensure
consistency, and based on standardized methods, inter-
viewer training and translation protocols, face-to-face in-
terviews were conducted in China (2008–10; response
93%), Ghana (2008–09; response 81%), India (2007–08;
response 68%), Mexico (2009–10; response rate 53%),
the Russian Federation (2007–10; response 83%) and
South Africa (2007–08; response 75%), as previously
published [23]. Full details regarding the probability
sampling design, cluster sampling strategies and
country-specific areas included in SAGE have been pub-
lished elsewhere [23]. Briefly, the SAGE questionnaire
consisted of household, individual and proxy question-
naires, a verbal autopsy, and appendices: the domains of
which are summarised in Table 1 [23].
Arthritis status: self-reported and symptom-based
For the current analyses, self-reported diagnosis of arth-
ritis (lifetime) was based on participant responses to the
question; “Have you ever been diagnosed with/told by a
health care professional you have arthritis (a disease of the
joints; or by other names rheumatism or osteoarthritis)?”
As a secondary endpoint, a symptom-based determination
of arthritis (yes/no for current within the previous
12 months) was also employed, by applying an algorithm
developed by the WHO SAGE study team [23]; questions
and the algorithm are presented in Table 2.
Socioeconomic position
SEP was measured using two key parameters of marital
status and educational attainment: the latter used due to
the inextricable link between education and skilled vs. un-
skilled labour, and thus financial remuneration for work.
Self-reported marital status was categorised for analyses
into three groups of: (i) never married, (ii) currently mar-
ried or cohabitating, and (iii) separated/divorced or
widowed. Participants were asked if they had ever been to
school; for those that indicated ‘yes’, they were also asked
to identify the highest level of education completed. Educa-
tion was categorised as (i) ‘no formal schooling’, (ii) less
than primary school, or primary school completed, (iii) sec-
ondary school completed, or high school (or equivalent)
completed, or (iv) college, pre-university or university com-
pleted, or post-graduate degree completed. Education
levels were mapped to an international standard [24].
Statistical analyses
Arthritis (self-reported and symptom-based) prevalence
and 95% confidence intervals (95%CI) were calculated
by implementing household level analysis weights separ-
ately for each of the six countries across 10-year age
strata (the 20–29 year age group was expanded to also
include those aged 18–19 years), sex, marital status and
education. Country-specific survey weightings were
applied, and weighted prevalence calculated for each
country. Adjustment of prevalence estimates for differ-
ences in the age structure across countries was accom-
plished by age-standardisation, using the direct method
of standardisation [25] and the WHO World Standard
Population distribution (%) as standard population [26].
Ten-year intervals were used for age categorisation.
Results
Country-specific numbers and proportions of the total
44,747 participants (total 57.1% women), were; China
n = 15,050 (33.6%), Ghana n = 5573 (12.5%), India
n = 12,198 (27.3%), Mexico n = 2752 (6.1%), the Russian
Federation n = 4947 (11.1%), and South Africa n = 4227
(9.5%). Across the entire study population, 5003 women
and 2664 men had (lifetime) self-reported arthritis (19.9%
and 14.1%, respectively), whilst 1220 women and 594 men
Table 1 Questionnaire sections included in the SAGE Wave 1
standardized survey instrument [23]
Questionnaire
section
Household roster Questions regarding the dwelling, income, transfers
[of family members] in and out of the household,
assets and expenditures
Individual
questionnaire
Questions regarding health and its determinants,
disability, work history, risk factors, chronic
conditions, caregiving, subjective well-being, health
care utilization and health systems responsiveness
Proxy
questionnaire
Questions regarding health, functioning, chronic
conditions, and health care utilization
Verbal autopsy Performed to ascertain the probable cause of death
for deaths in the household in the 24 months prior
to interview or between interview waves
Appendices Includes show-cards to assist with the interviews
Table 2 Symptom-based questions and the related algorithm
to ascertain prevalent arthritis, developed as part of the World
Health Organization SAGE Wave 1 [23]
Question number Question text and algorithm
1 During the last 12 months, have you experienced
pain, aching, stiffness or swelling in or around the
joints (like arms, hands, legs or feet) which were
not related to an injury and lasted for more than
a month?
2 During the last 12 months, have your experienced
stiffness in the joint in the morning after getting up
from bed, or after a long rest of the joint without
movement?
3 Did this stiffness last for more than 30 min?
4 Did this stiffness go away after exercise or
movement in the joint?
Algorithm If a participant responded with ‘yes’ to questions
1 and/or 2, and responded with ‘yes’ to question
3 and ‘no’ to question 4, then the participant was
categorised as having arthritis
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were identified as having (within previous 12 months)
symptom-based arthritis (4.8% and 3.1%, respectively).
Table 3 presents the country-specific proportional
responses (non-weighted) to the four symptom-based
questions (see Table 2), that were included in the
algorithm to determine symptom-based arthritis. For
women, proportions that reported ‘any pain during the
last 12 months’ or ‘any stiffness during the last 12
months’ were lowest for Mexico (28.4% [95% CI 26.3%–
30.9%] and 23.3% [95% CI 20.9%–26.0%], respectively)
and highest for the Russian Federation (48.4% [95% CI
46.4%–50.4%] and 50.5% [95% CI 48.8%–52.1%], respect-
ively). For men, the proportions that reported ‘any pain
during the last 12 months’ or ‘any stiffness during the
last 12 months’ were lowest for Mexico (20.1% [95% CI
17.5%–23.0%] and 16.1% [95% CI%CI 14.1%–18.3%], re-
spectively) and highest for the Russian Federation (32.9%
[95% CI 30.5%–35.5%] and 34.6% [95% CI 32.4%–
36.9%], respectively).
Table 4 presents the country-specific and sex-stratified
prevalence of self-reported arthritis (weighted), across
age strata, educational attainment and marital status.
For both sexes in each country, arthritis prevalence
increased proportionally with advancing age; with the
exception of women from China and men and women
from South Africa who had the greatest prevalence in
the age group of 60–69 years, all other groups showed a
peak in arthritis prevalence in the oldest age group
≥70 years. For women, the prevalence by country ranged
from 22.9% (95% CI 11.2%–41.1%) in Mexico to 45.7%
(95% CI 39.1%–52.3%) in the Russian Federation. For
men, prevalence ranged from 9.7% (95% CI 6.3%–14.5%)
in Mexico to 37.8% (95% CI 30.3%–46.0%) in the
Russian Federation. In each country, women who had
never been formally schooled or had completed less than
primary school had the highest prevalence of arthritis
compared to those with a greater level of educational at-
tainment. Higher arthritis prevalence was consistently
observed for women that were separated, divorced or
widowed (range: Russian Federation 36.4% [95% CI
29.1%–44.4%] to Ghana 11.7% [95% CI 8.9%–15.1%])
compared to those that were never married or currently
married (range: China 0.9% [95% CI 0.3%–3.0%] to
South Africa 12.1% [95% CI 5.5%–24.7%]). Similar to
women, men that had never been formally schooled had
the highest arthritis prevalence, with the exception of
men from the Russian Federation, for whom the greatest
prevalence was observed in those that had completed all
or some primary school level education (39.6% [95% CI
21.3%–61.4%]), however these numbers were small.
Compared to other categories, men that were never
married had the lowest arthritis prevalence (range:
Mexico 0.1% [95% CI 0.0%–0.5%] to India 3.9% [95% CI
1.5%–9.5%]). In China and India, men that were
currently married had the highest prevalence (11.9%
[95% CI 9.4%–14.8%], and 8.8% [95% CI 7.2%–10.7%],
respectively), whilst for all other countries, men that
were separated, divorced or widowed were observed to
have the highest arthritis prevalence (highest: Russian
Federation 33.5% [95% CI 13.3%–62.3%]).
Table 5 presents the country-specific and sex-stratified
prevalence of symptom-based arthritis prevalence
(weighted), across age strata, educational attainment and
marital status, for each LMIC. Patterns of symptom-
based arthritis prevalence were similar to self-reported
arthritis for both sexes; however, prevalence was lower
than observed for self-reported arthritis.
Figure 1 presents a box plot of the age-standardised
rates of self-reported arthritis, stratified by sex, across each
country (crude and age-standardised rates are presented
in Additional file 1: Online Table S1). For five of the six
LMICs, the standardised rates of arthritis for men were
approximately twice that observed for women; the excep-
tion was Ghana, where men had rates three times greater
than those observed for women (12% [95% CI 11%–13%]
vs. 4% [95% CI 3%–5%]). The highest rates of arthritis
were observed in the Russian Federation: for men the rate
was 38% (95% CI 36%–39%) and for women it was 17%
(95% CI 14%–20%).
Discussion
We present the prevalence of arthritis across age, sex
and different parameters of SEP in a large population-
based study spanning six LMICs. Across the countries
and for both sexes, higher arthritis prevalence was con-
sistently associated with older age and lower educational
attainment, whilst higher prevalence was also observed
in women, but not men, that were separated, divorced,
or widowed.
The pattern between advancing age and increasing
arthritis prevalence in LMICs appears similar to the pat-
tern observed in higher income countries [27]. However,
after age-standardisation, we observed in our current
study that the rates of arthritis in LMICs were greater
than those reported in higher income countries, specific-
ally for men from China, India, the Russian Federation
and South Africa. Compared to higher income countries,
higher age-standardised rates of arthritis were also ob-
served for women from the Russian Federation; however,
for the remaining five LMICs, rates appeared to be simi-
lar to those observed from higher income countries. Our
results indicate the importance of age-standardisation
when reporting prevalence data, in order that fair com-
parisons can be applied when discussing whether any
disparities in diseases exist between countries. In
addition to the peak of arthritis prevalence observed in
older age groups, we observed a sizeable proportion of
arthritis in younger age groups; prevalence that would
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have significant impacts on work capacity and social
roles. Indeed, whilst contextually different and focused
upon osteoarthritis, similar findings have been reported
in higher income countries [28, 29].
Ours are the first prevalence figures of arthritis to be
presented across different socioeconomic parameters for
residents of LMICs. Whilst the overall arthritis preva-
lence has been reported for some countries included the
Table 5 Country-specific symptom-related arthritis prevalence (weighted) across age strata, educational attainment and marital sta-
tus, stratified by sex
Women With symptom-related arthritis (n = 1220)
China
n = 201
Ghana
n = 290
India
n = 238
Mexico
n = 29
Russian Federation
n = 358
South Africa
n = 104
Age (years)
18–29 − − 0.9% (0.4%–1.8%) − − −
30–39 − 1.6% (0.4%–6.6%) 1.5% (0.7%–3.2%) − 12.5% (4.4%–30.7%) 0.2% (0.0%–1.7%)
40–49 0.3% (0.1%–1.3%) 3.3% (1.3%–7.9%) 2.8% (1.7%–4.4%) 1.2% (0.2%–8.0%) 2.3% (0.5%–9.5%) 2.4% (0.3%–15.7%)
50–59 4.1% (3.0%–5.7%) 11.5% (8.6%–15.2%) 5.9% (43%–8.0%) 0.7% (0.1%–4.1%) 4.3% (2.6%–7.1%) 6.2% (3.7%–10.2%)
60–69 4.0% (2.8%–5.8%) 16.5% (12.3%–21.9%) 5.6% (4.0%–7.9%) 1.5% (0.7%–3.2%) 10.0% (7.0%–14.2%) 5.5% (3.0%–9.8%)
70+ 5.6% (3.9%–7.9%) 18.6% (14.9%–23.0%) 6.7% (4.7%–9.7%) 2.1% (0.9%–4.7%) 20.1% (14.4%–27.4%) 5.6% (3.3%–9.2%)
Formal educationa
Never schooled 4.1% (3.3%–5.1%) 9.4% (6.9%–12.7%) 3.7% (2.9%–4.7%) 1.5% (0.5%–4.1%) 41.8% (16.6%–72.2%) 3.5% (1.7%–6.9%)
≤ Primary school 2.0% (1.3%–3.1%) 2.2% (1.4%–3.6%) 2.2% (1.5%–3.4%) 1.0% (0.3%–3.3%) 22.6% (14.3%–33.7%) 5.9% (2.3%–14.3%)
Secondary school 0.5% (0.3%–0.8%) 3.0% (1.3%–6.5%) 1.2% (0.6%–2.5%) 0.0% (0.0%–0.3%) 8.9% (4.9%–15.4%) 1.0% (0.4%–2.6%)
College 0.0% (0.0%–0.2%) − 1.1% (0.2%–6.4%) 0.0% (0.0%–0.3%) 4.3% (2.4%–7.5%) 0.3% (0.1%–1.2%)
Marital statusb
Never married − 1.9% (0.4%–9.0%) 1.1% (0.3%–3.7%) 0.3% (0.1%–0.9%) 1.7% (0.7%–4.2%) 2.6% (0.6%–11.2%)
Married 1.1% (0.9%–1.4%) 2.6% (1.7%–4.1%) 2.5% (1.9%–3.2%) 0.7% (0.2%–2.4%) 3.1% (1.9%–4.9%) 1.3% (0.6%–2.9%)
Divorced/widowed 4.2% (2.2%–7.9%) 10.8% (7.7%–15.0%) 4.8% (3.5%–6.7%) 0.6% (0.3%–1.4%) 18.0% (9.9%–30.5%) 3.4% (2.0%–5.6%)
Men With symptom-based arthritis (n = 594)
China
n = 138
Ghana
n = 170
India
n = 113
Mexico
n = 15
Russian Federation
n = 117
South Africa
n = 41
Age strata (years)
18–29 − 1.0% (0.1%–7.2%) 0.8% (0.1%–4.5%) − 2.3% (0.3%–16.2%) −
30–39 − 1.7% (0.5%–5.4%) 0.8% (0.2%–3.8%) − 5.2% (1.0%–22.2%) −
40–49 0.8% (0.2%–2.8%) 0.6% (0.1%–2.5%) 1.9% (0.8%–43%) − 1.9% (0.2%–13.4%) 1.7% (0.4%–6.6%)
50–59 2.3% (1.6%–3.1%) 3.8% (2.7%–5.4%) 2.6% (1.1%–6.2%) − 1.9% (0.9%–4.1%) 2.3% (1.0%–4.9%)
60–69 3.8% (3.3%–4.4%) 9.1% (6.7%–12.2%) 3.5% (2.0%–6.1%) 0.6% (0.2%–2.2%) 6.4% (3.3%–12.0%) 3.7% (1.8%–7.5%)
70+ 4.3% (3.5%–5.2%) 9.2% (6.9%–12.3%) 4.8% (3.0%–7.5%) 3.0% (1.5%–5.9%) 10.7% (6.9%–16.4%) 6.0% (2.4%–14.3%)
Formal educationa
None 4.8% (3.3%–6.8%) 5.6% (4.0%–7.7%) 2.7% (1.3%–5.5%) 1.5% (0.5%–3.8%) 3.4% (0.3%–27.7%) 4.2% (1.5%–10.8%)
≤ Primary school 1.2% (1.0%–1.6%) 1.9% (1.1%–3.2%) 1.2% (0.7%–1.9%) 0.2% (0.1%–0.6%) 10.4% (5.0%–20.4%) 1.6% (0.8%–3.4%)
Secondary school 1.0% (0.4%–2.3%) 1.4% (0.6%–3.1%) 2.0% (1.0%–4.2%) 0.1% (0.0%–0.5%) 3.9% (1.7%–9.0%) 0.9% (0.2%–5.4%)
College 0.1% (0.0%–0.4%) 0.7% (0.2%–2.2%) 0.4% (0.1%–1.6%) 0.2% (0.0%–1.4%) 1.4% (0.4%–5.3%) −
Marital statusb
Never married 0.9% (0.2%–5.0%) 1.5% (0.2%–8.8%) 1.6% (0.3%–8.2%) − 0.2% (0.0%–0.9%) 0.8% (0.2%–2.8%)
Married 1.1% (0.6%–1.8%) 2.5% (1.8%–3.4%) 1.8% (1.1%–2.7%) 0.3% (0.1%–0.5%) 3.7% (1.7%–8.0%) 1.4% (0.6%–3.2%)
Divorced/widowed 2.9% (1.7%–4.9%) 6.5% (3.8%–10.9%) 1.9% (0.6%–5.5%) 0.6% (0.1%–2.6%) 7.9% (2.9%–19.6%) 2.9% (0.7%–11.4%)
Data presented as proportions with 95% confidence intervals (95% CI)
Abbreviations: LMIC low and middle income countries, WHO World Health Organization
aCategories of formal education are; ≤primary school (less than primary school, or primary school completed); secondary school (secondary school completed, or
high school or its equivalent completed); college (college or pre-university completed, or post-graduate degree completed)
bCategories of marital status are; married (currently married or cohabiting); divorced/widowed (separated or divorced, or widowed)
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SAGE, specifically India [30] and China [31], we now
present age-standardised prevalence across all six coun-
tries (Additional file 1: Table S1). Higher prevalence of
arthritis among individuals with lower educational at-
tainment in LMICs, may be indicative of the inextricable
link between lower education and lower-skilled, highly
manual labour. Furthermore, these findings also
replicate the association observed in higher income
countries. For instance, lower educational attainment
has been associated with the prevalence of many chronic
diseases, including self-reported arthritis (non-specific)
[32], osteoarthritis [33] and rheumatoid arthritis [34].
Our observation of higher prevalence of arthritis in indi-
viduals that were divorced, widowed or separated, may
be related to those persons also more likely to be older.
However, and whilst speculative, it may plausibly be due
to having a greater workload that cannot shared with a
partner. Should these individuals also have lower educa-
tional attainment, any job-related exposures will likely
be manual and thus with greater biomechanical stress
on the joints due to increased exposure to heavy lifting,
repetitive movements and/or squatting [35, 36].
The prevalence of musculoskeletal diseases per se in
LMICs [3] will potentially have a greater impact than in
high income countries due to the reduced capacity of
LMICs to avoid and/or alleviate the impact at individual
and national levels. This is especially pertinent given that
global NCD initiatives do not list musculoskeletal
diseases within the ‘top four’ [3]. In LMICs where pain
management is less than optimal [37], the burden of
chronic, and possibly untreated, pain will be com-
pounded by social and environmental stressors that
require individuals work and fulfil community roles re-
gardless of pain. Indeed, data from a WHO collaboration
reported that between 5 and 33% of individuals in
LMICs experience chronic pain on a daily basis [38].
Similarly, we observed a sizeable proportion of
respondents to have stiffness lasting longer than 30 min
and which did not alleviate with movement; these char-
acteristics are indicative of chronic pain, and potentially
suggest inflammatory arthropathy. In addition, diseases
such as fibromyalgia are likely to cause joint pain,
however, we are unable to determine if this, and similar
issues, may have biased responses to symptomatology-
related questions. Any ‘treatment gap’ is at odds with
the WHO Constitution, which recognises “…the highest
attainable standard of health as a fundamental right of
every human being” [39], however, LMICs experience a
disproportionately lower likelihood of achieving that
standard. We speculate that resource-poor populations,
where ‘informal workers’ are central to community
structure, are most at risk of worsening poverty levels
due to increased YLD attributable to highly prevalent,
and potentially undertreated, arthritis. It is important to
note that whilst the burden of non-communicable
diseases is increasing, there is a concurrent decline in
the burden of infectious diseases [2]. Given this, more
attention must be given to the management of diseases
such as arthritis in LMICs: action on musculoskeletal
diseases per se in LMICs present opportunities for such
action [3]. Models of care (MoC) for musculoskeletal
diseases have been developed and implemented in the
LMICs of The Philippines, Malaysia, Bangladesh and
Myanmar [40]. Despite mixed results, a four-step
process was designed to inform future development of
musculoskeletal-related MoC for implementation in
LMICs; (i) identify the scale of the problem, (ii) identify
the need, (iii) develop the action plan (including com-
munity engagement and addressing workforce capacity),
and (iv) employ a coordinated approach to implement-
ing the intervention program/MoC [40].
Despite advances in diagnosis and treatment of
arthritis during the last few decades in higher income
countries [16], these advances have not impacted on
a b
Fig. 1 Box plot presenting the direct age-standardised prevalence estimates (%) and 95% confidence intervals of self-reported arthritis diagnosis
for each of the lower to middle income countries, for women (a) and men (b)
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LMICs, which are primarily resource-poor. Gross
domestic product and health care expenditures per
capita are strongly correlated [14, 41]. Governments in
LMICs are constrained by competitive social, economic,
health- and poverty-related issues [7]; this frequently re-
sults in chronic diseases such as arthritis achieving lower
priority when urgent health needs are considered in an
environment with poor education, scarce resources, and
rapid population growth [7, 42]. Not only is suboptimal
access to healthcare a concern, but the cost of healthcare
may be many-fold the gross domestic product, and thus
unattainable for the majority of the population of LMICs
[5]. For many individuals and households in LMIC, there
are inadequate financial resources to manage the cost of
chronic disease, with an impoverishing effect of paying
for healthcare services out-of-pocket [43]. In order to
address the problem of out-of-pocket healthcare ex-
penses, the WHO is encouraging countries to provide
universal health coverage [7]. For LMICs the provision
of universal health coverage may be in the form of
community-based health insurance schemes, whereby
the community voluntarily raises, pools, allocates,
purchases and supervises the health financing arrange-
ment [7, 44]. Whilst there are some national efforts to
prioritise healthcare resources and achieve universal
health coverage, these schemes are likely to focus on
supporting healthcare for diseases that cause early
mortality rather than those that result in disability.
Our study has a number of strengths. The SAGE study
consists of a large multi-national cohort, and our
population for this analysis encompassed almost 45,000
participants. The integrity and coordination of these data
is overseen by WHO, in close collaboration with leading
research institutions in each of the countries, and with a
level of involvement from national health authorities
[23]. The use of a standardized survey instrument and
methods for SAGE Wave 1, the recruitment of represen-
tative samples, and the application of country-specific
weightings to calculate our prevalence estimates have
enabled comparison with similar surveys conducted in
higher income countries. In addition, the use of stan-
dardized tools to measure SEP in each of the countries
in SAGE enables us to undertake between-country com-
parisons. Our findings build on the prevalence data re-
ported by the GBD Study, whereby estimates were based
on systematic reviews of published data on incidence,
prevalence, and severity; however, for some LMICs only
limited data were available [45]. Our study also builds
on previous analyses using the SAGE dataset, as no
study to date has presented arthritis prevalence figures
across parameters of SEP.
This study also has some limitations. We acknow-
ledge that SAGE chronic disease data are self-
reported, and thus may be subject to recall bias and
potential inaccuracy with a subsequent uncertainty of
estimates. However, the self-reported arthritis ques-
tion is similar to that used for other large population
level studies, including those reported by the Centers
for Disease Control Arthritis Program in the United
States [46], and self-reported arthritis has also been
reported as a sensitive measure for public health sur-
veillance [47]. It is possible that limited access to
healthcare professionals in LMICs may lead to an
underestimation of arthritis prevalence, and those
who have arthritis but have not yet sought care may
have been missed. In addition, it may be possible that
in many countries diagnoses of arthritis may be made
by a non-medical healthcare provider, thus introdu-
cing some ambiguity in responses to the diagnosis
question. Yet here, the symptom-reported prevalence,
where access to healthcare professionals would be re-
moved from the equation, indicated an even lower
burden of arthritis than by self-reported diagnosis; an
issue that may also be related to diagnosed arthritis
being across the lifetime, whilst symptom-based arth-
ritis was within the previous 12 months. Our study
does not link prevalence data with disability; however
it should be noted that arthritis has highly variable
impacts on the person. A high proportion of SAGE
Wave 1 participants indicated that they had no formal
education (~50%); this may explain the level of miss-
ing data pertaining to the ‘highest level of educational
attainment’ variable. However, missing data may also
be attributable to the WHO data collection ‘Individual
Questionnaire’ tool, which did not include a category
for those that had completed primary school but who
had not completed secondary school. It has been re-
ported that, in several countries, urban dwellers were
more likely to refuse to participate in SAGE [23],
which may present a bias toward rural-based participants;
however, the high proportion of rural residents may
conversely be considered a key strength of the SAGE
dataset as non-metropolitan groups are commonly
under-represented in population-based surveys. We
acknowledge that the six countries differ substantially
in terms of culture, society, and healthcare system,
and thus our pooled estimates should be considered
in this light. Finally, the response rates were relatively
low for Mexico (53%), due to a short time-frame for
data collection, although response rates for all other
countries in SAGE Wave 1 were 75% or greater, with
the exception of India at 68% [23].
Conclusions
In conclusion, we have identified a high prevalence of
arthritis in LMICs. For people living in LMIC, functional
ability and mobility is imperative to survival, and our
findings therefore have implications for prioritising
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healthcare resources toward arthritis prevention and
treatment in relatively resource-poor countries. It is
plausible that, especially for residents of LMICs, the high
prevalence of arthritis may limit their ability to finan-
cially and/or materially support themselves. Similarly,
poverty and lower educational attainment may predis-
pose populations to manual labour, and subsequent pre-
disposition to diseases such as osteoarthritis. Future
work will focus on occupational types and occupational
activities as risk factors for arthritis and related symp-
tomatology. Our current findings have implications for
national efforts to achieve universal health coverage and
to prioritise healthcare resources toward preventing and/
or treating arthritis.
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